Loading...
Market
Which country will first approve the PfSPZ Vaccine for pre-pregnancy malaria prevention by June 2025?
2
Resolution / Starting Odds
Mali • 25%
Nigeria • 25%
Ghana • 25%
Other • 25%
Official announcements from the respective country's health ministry or relevant governmental health agencies
Story
Pre-Pregnancy Malaria Vaccine Shows Promise in Mali Trials
Aug 15, 2024, 06:26 AM
Recent findings from a trial conducted in Mali indicate that a pre-pregnancy malaria vaccine, known as the PfSPZ Vaccine, could significantly protect women and their babies from malaria. The research, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), involved two randomized, double-blind, placebo-controlled phase 1 and 2 trials. Scientists have hailed the results as a 'tremendous advance' in preventing the deadly parasitic disease in pregnant women. The trial's success could pave the way for improved malaria prevention strategies for women anticipating pregnancy.
View original story
Similar markets
Kenya • 25%
Uganda • 25%
Tanzania • 25%
Other • 25%
Kenya • 25%
Tanzania • 25%
Uganda • 25%
Other • 25%
Kenya • 25%
Uganda • 25%
Tanzania • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
USA • 25%
UK • 25%
South Africa • 25%
Other • 25%
Canada • 25%
United Kingdom • 25%
Australia • 25%
Other • 25%
South Africa • 25%
Kenya • 25%
Nigeria • 25%
Other • 25%
United States • 25%
South Africa • 25%
India • 25%
Other • 25%
